Abstract:BackgroundSarcopenia is a known risk factor for poor outcomes across many chronic diseases. The impact on outcomes of both pre-existing sarcopenia and acute muscle wasting (AMW) in acute critical illness caused by sepsis remain unclear. MethodsWe conducted a prospective longitudinal cohort study of critically ill patients with intra-abdominal sepsis utilizing abdominal computed tomography at sepsis onset to determine baseline skeletal muscle index (SMI). Biomarkers of inflammation and catabolism were measured through 28 days while hospitalized. We performed follow-up evaluations of strength and physical function at 3, 6, and 12 months, with interval CT analyses at 3 and 12 months to evaluate changes in muscle mass. Measured clinical outcomes included development of chronic critical illness (≥14 days in intensive care with persistent organ dysfunction), long-term functional status, and 1 year mortality. ResultsAmong 47 sepsis patients enrolled (mean age 53 ± 14 years), half (n = 23; 49%) were sarcopenic at baseline. Overall, sepsis patients exhibited acute and persistent muscle wasting with an average 8% decrease in SMI from baseline at 3 months (P = 0.0008). Sarcopenic (SAR) and non-sarcopenic (NSAR) groups were similar in regards to age and comorbidity burden. SAR patients had greater acute physiologic derangement (APACHE II, 18 vs. 12.5), higher incidence of multiple organ failure (57% vs. 17%), longer hospital (21 vs. 12 days) and intensive care unit length of stays (13 vs. 4 days), and higher inpatient mortality (17% vs. 0%; all P < 0.05). Pre-existing SAR was a strong independent predictor of early death or developing chronic critical illness (odds ratio 11.87, 95% confidence interval CI 1.88–74.9; P = 0.009, area under the curve 0.880) and was associated with significantly higher risk of 1-year mortality (34.9% vs. 4.2%, p = 0.007). Lower baseline SMI was also predictive of poor functional status at 12 months (OR 0.89, 95% confidence interval 0.80–0.99; p = 0.039, area under the curve 0.867). Additionally, SAR patients had AMW with persistent muscle mass loss at 3 months that was associated with decreased health-related quality of life and SF-36 physical function domains (P < 0.05). Persistent AMW at 3 months was not predictive of mortality or poor functional status, with return to near-baseline muscle mass among sepsis survivors by 6 months. ConclusionsCritically ill patients have an acute and persistent loss of muscle mass after intra-abdominal sepsis, which is associated with decreased health-related quality of life and physical function at 3 months. However, pre-existing sarcopenia, rather than persistent acute muscle mass loss at 3 months after sepsis, is independently associated with poor long-term functional status and increased 1 year mortality.

Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis

Sarcopenia As A Predictor of Mortality among the Critically Ill in an Intensive Care Unit: A Systematic Review and Meta-Analysis

Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications

Impact of Sarcopenic Obesity on 30-Day Mortality in Critically Ill Patients with Intra-Abdominal Sepsis.

Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age

Bedside assessment of sarcopenia in hospitalized patients with liver cirrhosis: Magnitude and clinical implications

Sarcopenia is Associated with Short- and Long-Term Mortality in Patients with Acute-on-chronic Liver Failure

Muscle wasting associated co-morbidities, rather than sarcopenia are risk factors for hospital mortality in critical illness

Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis

Sarcopenia in Cirrhosis: Epidemiology, Diagnosis, Management and Prognosis

Clinical relevance of sarcopenia in patients with cirrhosis

S1858 Impact of Sarcopenia on Outcomes in Cirrhotic Patients: Nationwide Inpatient Sample Study 2016-2020

CT-based sarcopenia assessment: Predicting outcomes in acute infection patients

The sarcopenia index is an effective predictor for malnutrition in patients with liver cirrhosis

Sarcopenia Is Associated With Increased Mortality in Patients With Necrotizing Soft Tissue Infections

The impact of sarcopenia and acute muscle mass loss on long‐term outcomes in critically ill patients with intra‐abdominal sepsis

Comparative analysis of Sarcopenia in hospitalized elderly: exploring the impact of liver cirrhosis

The Importance of Sarcopenia As a Prognostic Predictor of the Clinical Course in Acute Severe Ulcerative Colitis Patients.

Prevalence and predictive value of sarcopenia in hospitalized patients with ischemic colitis

Establishment of a prognostic model for hospitalized cirrhotic patients with infection based on lumbar muscle mass

Association of sarcopenia, as defined based on the skeletal muscle index, with mortality and morbidity after cardiac surgery: a retrospective cohort study